[
  {
    "ts": null,
    "headline": "Becton Dickinson & Co. stock outperforms competitors despite losses on the day",
    "summary": "Becton Dickinson & Co. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=9c5495d11d65b304746c74ed1d6ee961df832cf4eee5d315c71b27c76655314a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752857220,
      "headline": "Becton Dickinson & Co. stock outperforms competitors despite losses on the day",
      "id": 136052909,
      "image": "",
      "related": "BDX",
      "source": "MarketWatch",
      "summary": "Becton Dickinson & Co. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=9c5495d11d65b304746c74ed1d6ee961df832cf4eee5d315c71b27c76655314a"
    }
  },
  {
    "ts": null,
    "headline": "Vascular Access Devices Company Evaluation Report 2025 | Becton Dickinson, Teleflex, and ICU Medical Strengthen Global Leadership Through Strategic Acquisitions and Product Innovation",
    "summary": "The Vascular Access Devices Market Companies Quadrant delivers a thorough analysis of the global vascular access devices sector. Highlighting prominent players, innovations, and trends, it identifies the top 25 companies as quadrant leaders among over 100 evaluated. Vascular access devices (VADs), crucial for treatments like chemotherapy and dialysis, are set to grow from USD 5.99 billion in 2024 to USD 9.05 billion by 2030 at a 7.1% CAGR, fueled by rising demand and investments despite a skille",
    "url": "https://finnhub.io/api/news?id=b9eb0cd4d34561792c0fb7f977cd1ddf945b75ae5ba44590ca7f244454c3bbde",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752851220,
      "headline": "Vascular Access Devices Company Evaluation Report 2025 | Becton Dickinson, Teleflex, and ICU Medical Strengthen Global Leadership Through Strategic Acquisitions and Product Innovation",
      "id": 136006070,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "The Vascular Access Devices Market Companies Quadrant delivers a thorough analysis of the global vascular access devices sector. Highlighting prominent players, innovations, and trends, it identifies the top 25 companies as quadrant leaders among over 100 evaluated. Vascular access devices (VADs), crucial for treatments like chemotherapy and dialysis, are set to grow from USD 5.99 billion in 2024 to USD 9.05 billion by 2030 at a 7.1% CAGR, fueled by rising demand and investments despite a skille",
      "url": "https://finnhub.io/api/news?id=b9eb0cd4d34561792c0fb7f977cd1ddf945b75ae5ba44590ca7f244454c3bbde"
    }
  },
  {
    "ts": null,
    "headline": "The Davenport Insider Buying Fund Q2 2025 Commentary",
    "summary": "Insider buying fuels Davenportâs contrarian bets in semis, housing, and LNG. See what signals fund managers trust when markets move against the grain.",
    "url": "https://finnhub.io/api/news?id=ca3d15c8d36faacca7f0f921829ec74383fca064ac9254718d546c4727f4a581",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752820800,
      "headline": "The Davenport Insider Buying Fund Q2 2025 Commentary",
      "id": 136000884,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2152882467/image_2152882467.jpg?io=getty-c-w1536",
      "related": "BDX",
      "source": "SeekingAlpha",
      "summary": "Insider buying fuels Davenportâs contrarian bets in semis, housing, and LNG. See what signals fund managers trust when markets move against the grain.",
      "url": "https://finnhub.io/api/news?id=ca3d15c8d36faacca7f0f921829ec74383fca064ac9254718d546c4727f4a581"
    }
  },
  {
    "ts": null,
    "headline": "The Davenport Balanced Fund Q2 2025 Commentary",
    "summary": "Davenport blends dividend discipline, bond yield upside, and contrarian equity picks in DBALX. See how balanced investing still finds value in 2025.",
    "url": "https://finnhub.io/api/news?id=4bdb422e2c4856f5d9f3007eff0a2fbd75d7735fa999ca6fde264ed6f71dd73f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752820500,
      "headline": "The Davenport Balanced Fund Q2 2025 Commentary",
      "id": 136000852,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2010464790/image_2010464790.jpg?io=getty-c-w1536",
      "related": "BDX",
      "source": "SeekingAlpha",
      "summary": "Davenport blends dividend discipline, bond yield upside, and contrarian equity picks in DBALX. See how balanced investing still finds value in 2025.",
      "url": "https://finnhub.io/api/news?id=4bdb422e2c4856f5d9f3007eff0a2fbd75d7735fa999ca6fde264ed6f71dd73f"
    }
  },
  {
    "ts": null,
    "headline": "The Davenport Value & Income Fund Q2 2025 Commentary",
    "summary": "The Davenport Value & Income Fund Q2 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=8fe250ebddd0c5cd485b556d16dd47deb781d90003a77552d4b3581b3cadd026",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752819300,
      "headline": "The Davenport Value & Income Fund Q2 2025 Commentary",
      "id": 136000824,
      "image": "",
      "related": "BDX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=8fe250ebddd0c5cd485b556d16dd47deb781d90003a77552d4b3581b3cadd026"
    }
  }
]